Biotech · Private company · San Marcos, CA, US
Neurosant Therapeutics LLC
Track this companyFree. Adds Neurosant Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Therapeutics that Correct the Underlying Cause of Smith-Magenis Syndrome (SMS)Fiscal year 2025 · $195.9KNIH RePORTER 5R21HD115076-02 · fetched Nov 12, 2026
- Therapeutics that Correct the Underlying Cause of Smith-Magenis Syndrome (SMS)Fiscal year 2024 · $189.1KNIH RePORTER 1R21HD115076-01 · fetched Nov 12, 2026